Opaleye Management Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Opaleye Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $1.64 Million - $2.63 Million	-25,000 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$64.07 - $91.75 $5.7 Million - $8.17 Million	-89,000 Reduced 78.07%	25,000 $1.71 Million
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $22,774 - $34,384	-350 Reduced 0.31%	114,000 $9.77 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $3.32 Million - $8.49 Million	114,350 New	114,350 $8.36 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $4.54 Million - $9.45 Million	-165,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $204,300 - $288,250	5,000 Added 3.13%	165,000 $8.98 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $373,800 - $494,700	10,000 Added 6.67%	160,000 $6.68 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $5.97 Million - $10.1 Million	150,000 New	150,000 $6.57 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.68B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.